Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
China flag China · Delayed Price · Currency is CNY
12.73
-0.35 (-2.68%)
Sep 10, 2026, 2:10 PM CST

Jiangsu Yahong Meditech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-492.77-416.38-384.06-400.43-246.55-234.95
Depreciation & Amortization
38.6735.2230.5319.2711.557.4
Other Amortization
3.33.264.435.214.484.29
Loss (Gain) From Sale of Assets
-0.050-0.05--0.02
Asset Writedown & Restructuring Costs
0.210-0.031.841.19
Loss (Gain) From Sale of Investments
-18.5-21.85-24.46-25.39-57.58-16.37
Provision & Write-off of Bad Debts
3.222.042.70.450.020.29
Other Operating Activities
-3.66-2.548.283.94-9.072.51
Change in Accounts Receivable
-103.15-68.02-89.33-45.913.5-20.8
Change in Inventory
-14.12-14.71-3.451.15-0.81-0.79
Change in Accounts Payable
62.1253.9911.1727.2233.7524.96
Change in Other Net Operating Assets
6.2317.520.117.296.9560.74
Operating Cash Flow
-518.4-411.79-424.95-398.19-241.96-171.52
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-59.54-19.12-5.79-101.63-26.61-42.4
Sale of Property, Plant & Equipment
0.030.010.07--0
Investment in Securities
16554.86804.84-274.89-1,291165.73
Other Investing Activities
-01.87-1.879.72--
Investing Cash Flow
105.4937.62797.25-366.8-1,318123.33

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---73.4--
Long-Term Debt Issued
-288.0566.2---
Total Debt Issued
338.7288.0566.273.4--
Long-Term Debt Repaid
--85.88-90.66-11.36-8.99-4.52
Lease Payments
-10.79-19.68-17.26-11.36-8.99-4.52
Net Debt Issued (Repaid)
96.02202.17-24.4662.04-8.99-4.52
Issuance of Common Stock
14.918.07---2,396
Repurchase of Common Stock
---50.06---
Common Dividends Paid
-6.12-4.08-2.49-0.41--
Other Financing Activities
26.74--0.39-22.05-8.03
Financing Cash Flow
131.55206.16-77.0162.01-31.052,384

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.33-1.68-1.950.767.35-2
Net Cash Flow
-282.69-169.69293.34-702.22-1,5842,334

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-577.94-430.92-430.74-499.82-268.57-213.92
Free Cash Flow Growth
------
Free Cash Flow Margin
-191.22%-155.50%-213.70%-3634.18%-1029206.22%-4676788.98%
Free Cash Flow Per Share
-1.02-0.77-0.76-0.84-0.47-0.46
Levered Free Cash Flow
-554.22-275.37-271.45-334.62-204.07-106.45
Unlevered Free Cash Flow
-549.58-270.2-267.23-332.76-203.59-106.15
Free Cash Flow After Leases
-588.73-450.59-448-511.19-277.56-218.43

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
9.5322.213.751.94-22.57-2.7
Change in Working Capital
-48.83-11.54-62.33-1.2653.3564.11